Advanced search×

Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs.

J Am Anim Hosp Assoc 40(1):29-41 (2004) PMID 14736903

Topical 0.1% tacrolimus was used for treatment of localized lesions associated with 10 cases of discoid lupus erythematosus (DLE) and two cases of pemphigus erythematosus (PE) either as a sole therapy (n=2) or as an adjunctive treatment (n=10). Eight of 10 dogs with DLE and both dogs with PE were improved following 8 weeks of topical application. In six of the eight dogs that improved, other medications were discontinued. No adverse effects in clinical or laboratory parameters were noted throughout the study.

Version: za2963e q8zad q8zb1 q8zcf q8zdd q8ze4 q8zfe q8zg7

Similar articles you may find interesting…

  1. A hospital-based study to evaluate the incidence pattern of group A streptococcal throat infections from different age group patients.

    J Indian Med Assoc 108(2):81-3 (2010) PMID 20839562

    Streptococcus pyogenes(group A) is a major pathogen capable of causing a wide range of diseases in different age group of people. In this study 100 patients were selected who presented with the complaint of sore throat. All the patients were divided in four age groups. Streptococcus pyogenes colonie...
  2. Survey of heartworm prevention practices among members of a national hunting dog club.

    J Am Anim Hosp Assoc 47(3):161-9 (2011) PMID 21498598

    Surveillance data indicate that failures have been reported for virtually all heartworm prevention product categories. Resistance of third and fourth stage larvae of Dirofilaria immitis to macrocyclic lactones, lack of compliance, other unknown factors, or a combination of these reas...
  3. Speaking out.

    J Am Anim Hosp Assoc 40(1):4; author reply 5 (2004) PMID 14736897